0001181431-13-015377.txt : 20130307 0001181431-13-015377.hdr.sgml : 20130307 20130307164744 ACCESSION NUMBER: 0001181431-13-015377 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130305 FILED AS OF DATE: 20130307 DATE AS OF CHANGE: 20130307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FERRARI LOUIS CENTRAL INDEX KEY: 0001513697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 13673975 MAIL ADDRESS: STREET 1: 765 WARREN STREET CITY: WARRREN STREET STATE: NJ ZIP: 07090 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd373150.xml FERRARI FORM 4 X0306 4 2013-03-05 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001513697 FERRARI LOUIS SAVIENT PHARMACEUTICALS, INC. 400 CROSSING BLVD. BRIDGEWATER NJ 08807 1 1 0 0 President and CEO Common Stock 308459 D Option to Purchase Common Stock 0.94 2013-03-05 4 A 0 180000 0 A 2023-03-05 Common Stock 180000 180000 D Option to Purchase Common Stock 2.26 2013-03-05 4 A 0 60200 0 A 2022-02-01 Common Stock 60200 60200 D Option to Purchase Common Stock 0.56 2012-07-09 4 A 0 150000 0 A 2022-07-09 Common Stock 150000 150000 D These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013. These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012. These performance options were granted effective July 9, 2012 and vest, if at all, in proportional 25% increments if the closing price of Savient's common stock during any period of 30 consecutive calendar days equals or exceeds certain pre-agreed share prices. Philip K. Yachmetz as attorney-in-fact for Louis Ferrari 2013-03-07